Regulation of TNF-α by 1α,25-dihydroxyvitamin D3 in human macrophages from CAPD patients
- 1 January 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (1) , 69-75
- https://doi.org/10.1046/j.1523-1755.2001.00467.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Elevated superoxide generation in mononuclear phagocytes by treatment with 1 alpha hydroxyvitamin D3Journal of the American Society of Nephrology, 1995
- Effect of 1,25-Dihydroxyvitamin D on the Immune Activity of Peritoneal Macrophages in Continuous Ambulatory Peritoneal Dialysis PatientsNephron, 1995
- Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3Blood, 1992
- Immunological properties of vitamin D analogues and metabolitesBiochemical Pharmacology, 1992
- Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patientsKidney International, 1991
- VITAMIN D AND HUMAN LEUKAEMIABritish Journal of Haematology, 1989
- Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.Journal of Clinical Investigation, 1987
- Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: Inhibition of interleukin-2 and augmentation of interleukin-1 productionCellular Immunology, 1986
- Interactions of 1,25-dihydroxyvitamin D3 and the immune systemMolecular and Cellular Endocrinology, 1985
- Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.Proceedings of the National Academy of Sciences, 1981